CompletedPhase 4

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

France57 participantsStarted 2000-04-30

Plain-language summary

This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients born with IUGR enrolled in trial GHRETARD/F/1/F * Bone age below 14 years in boys and 12 years in girls Exclusion Criteria: * Bone age above 14 years in boys and 12 years in girls

What they're measuring

Glucose tolerance as assessed by hyperglycaemia induced by oral ingestion

Trial details

NCT IDNCT01734447

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2003-04-30

View on ClinicalTrials.gov More Foetal Growth Problem trials